Intellia Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:NTLA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -148.93 M-99.62 M-76.9 M-69.28 M-117.35 M -363.15 M Cash from investing activities 94.33 M106.91 M-741 K27.53 M66.31 M 200.01 M Cash from financing activities 014.65 M114.86 M1.98 M33.57 M 165.06 M Free cash flow -148.93 M-99.62 M-76.9 M-69.28 M-117.35 M -363.15 M

News

Intellia Therapeutics: An Overvalued Biotech With Little To No Commercial Potential (NTLA)

Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable (PRME)

NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?

Wall Street Doubles Down on Wolfspeed Short Positions Over Cash Burn Fears

Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?

The Disinflation Trade Has A New Address: Genomics

NTLA Posts Strong Additional Phase III Data From HAE Study, Stock Up

Strength Seen in Intellia Therapeutics (NTLA): Can Its 23.2% Jump Turn into More Strength?

Intellia Surges; Can Its Gene-Editing Drug Solve The Chronic Treatment Problem?

Intellia Therapeutics (NTLA) Down 7.9% Since Last Earnings Report: Can It Rebound?

Intellia Therapeutics Stock: Steady Progress, Historic Commercial Approval (NASDAQ:NTLA)

ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?